Aldeyra Therapeutics, Inc. (ALDX)
4.63
+0.22
(+4.99%)
USD |
NASDAQ |
Jan 16, 16:00
4.61
-0.02
(-0.43%)
After-Hours: 20:00
Aldeyra Therapeutics EPS Diluted (Quarterly): -0.1279 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | -0.3822 |
| ADMA Biologics, Inc. | 0.1489 |
| Exelixis, Inc. | 0.695 |
| Altimmune, Inc. | -0.2126 |
| Actinium Pharmaceuticals, Inc. | -0.1645 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.688M |
| Total Expenses (Quarterly) | 7.688M |
| Enterprise Value | 218.80M |
| Earnings Yield | -15.59% |
| Normalized Earnings Yield | -15.59 |